Back

Platelet dysfunction, liver fibrosis and adverse outcomes in individuals with ischemic heart disease: a post-hoc analysis of the prospective observational EVA study

30 August 2026 (10:15 - 11:00)
Organised by: Logo
Congress Presentation Part of: Residual risk in ischaemic heart disease: thrombotic and vascular mechanisms Thrombosis, Platelets, and Coagulation ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Giulia Andrea Guadalupi

Sapienza University of Rome, Rome (Italy)

5 More presentations in this session

Presentation thumbnail
Effects of icosapent ethyl on coagulation biomarkers and their association with event‑free survival in high‑risk cardiovascular patients: a post hoc analysis of the REDUCE-IT
Ms A. Kuenzli (Schlieren, CH)
Abstract Slides Video
Presentation thumbnail
Infection drives excessive platelet inhibition during P2Y12 inhibitor therapy in coronary artery disease
Doctor L. Weiss (Wuerzburg, DE)
Abstract Slides Video
Presentation thumbnail
Hypertension-associated acetate deficiency enhances platelet activation and thrombosis via Olfr78
Doctor Y. Chen (Shanghai, CN)
Abstract Slides Video
Presentation thumbnail
A dense fibrin network favours layered plaque formation in the infarct-related artery in patients with ST-segment elevation myocardial infarction
Doctor K. Karwat (Krakow, PL)
Abstract Slides Video
Presentation thumbnail
S1P as a novel target to address adverse outcomes following acute myocardial infarction
Miss E. Pavlidou (Schlieren, CH)
Abstract Slides Video

Access the full session

Session thumbnail
Residual risk in ischaemic heart disease: thrombotic and vascular mechanisms

The Event

Event poster

ESC Congress 2026

30 August 2026 10:15 CET
You may be interested in
thumbnail
Congress Presentation
Investigating the influence of possible liver fibrosis on mortality in patients with coronary artery disease - a post-hoc ISCHEMIA trial analysis
30 August 2024
thumbnail
Congress Presentation
Impact of baseline thrombocytopenia on bleeding and mortality after Venous thromboembolism: from the COMMAND VTE Registry-2
27 August 2023
thumbnail
Congress Presentation
Endotype distribution and response to tailored medical therapy in patients with myocardial bridging and ischaemia with non-obstructive coronary arteries
30 August 2026
thumbnail
Congress Presentation
Prothrombotic fibrin clot phenotype as a risk factor for persistent left ventricular thrombus following acute myocardial infarction
1 September 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources